Advertisement

Role of Vascular Endothelial Growth Factor in Regulation of Angiogenesis

  • Napoleone Ferrara
Part of the Cancer Drug Discovery and Development book series (CDD&D)

Abstract

The development of a vascular supply is a fundamental requirement for organ development and differentiation during embryogenesis, as well as for wound healing and reproductive functions in the adult (1). Angiogenesis is also implicated in the pathogenesis of a variety of disorders: proliferative retinopathies, age-related macular degeneration, tumors, rheumatoid arthritis, and psoriasis (1,2).

Keywords

Vascular Endothelial Growth Factor Vascular Endothelial Growth Factor Receptor Vascular Endothelial Growth Factor Expression Bullous Pemphigoid Vascular Endothelial Growth Factor mRNA 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1 27–31. PubMedCrossRefGoogle Scholar
  2. 2.
    Garner, A. (1994) Vascular Diseases 2nd ed. Marcel Dekker, New York. Google Scholar
  3. 3.
    Folkman, J. and Shing, Y. (1992) Angiogenesis. J. Biol. Chem. 267, 10,931–10, 934.Google Scholar
  4. 4.
    Risau, W. (1997) Mechanisms of angiogenesis. Nature 386, 671–674.PubMedCrossRefGoogle Scholar
  5. 5.
    Good, D., Polverini, P., Rastinejad, F., Beau, M., Lemons, R., Frazier, W., and Bouck, N. (1990) Proc. Natl. Acad. Sci. USA 87 6624–6628. Google Scholar
  6. 6.
    DiPietro, L. A. Thrombospondin as a regulator of angiogenesis, in Regulation of Angiogenesis (Goldberg, I. and Rosen, E., eds.), Springer Verlag, Berlin, pp. 295–314.Google Scholar
  7. 7.
    Ferrara, N., Clapp, C., and Weiner, R. (1991) 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129, 896–900.PubMedCrossRefGoogle Scholar
  8. 8.
    O’Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., et al. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315–328.PubMedCrossRefGoogle Scholar
  9. 9.
    O’Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., et al. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277–285.PubMedCrossRefGoogle Scholar
  10. 10.
    Ferrara, N. and Davis-Smyth, T. (1997) Biology of vascular endothelial growth factor. Endocr. Rev. 18, 4–25.PubMedCrossRefGoogle Scholar
  11. 11.
    Ferrara, N., Carver Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K. S., et al. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439–442.PubMedCrossRefGoogle Scholar
  12. 12.
    Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435–439.PubMedCrossRefGoogle Scholar
  13. 13.
    Pearlman, J. D., Hibberd, M. G., Chuang, M. L., Harada, K., Lopez, J. J., Gladstone, S. R., et al. (1995) Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis [see comments]. Nature Med. 1, 1085–1089.PubMedCrossRefGoogle Scholar
  14. 14.
    Takeshita, S., Zhung, L., Brogi, E., Kearney, M., Pu. L.-Q., Bunting, S., et al. (1994) Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments collateral vessel formation in a rabbit ischemic hind-limb model. J. Clin. Invest. 93, 662–670.PubMedCrossRefGoogle Scholar
  15. 15.
    Isner, J. M., Pieczek, A., Schainfeld, R., Blair, R., Haley, L., Asahara, T., et al. (1996) Clinical evidence of angiogenesis after arterial gene transfer of phVEGF 165 inpatient with ischaemic limb. Lancet 348, 370–374.Google Scholar
  16. 16.
    Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem. Biophys. Res. Commun. 189, 824–831.PubMedCrossRefGoogle Scholar
  17. 17.
    Nicosia, R., Nicosia, S. V., and Smith, M. (1994) Vascular endothelial growth factor, platelet-derived growth factor and indulin-like growth factor stimulate angiogenesis in vitro. Am. J. Pathol. 145, 1023–1029.PubMedGoogle Scholar
  18. 18.
    Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306–1309.PubMedCrossRefGoogle Scholar
  19. 19.
    Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181, 902–906.PubMedCrossRefGoogle Scholar
  20. 20.
    Unemori, E. N., Ferrara, N., Bauer, E. A., and Amento, E. P. (1992) Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J. Cell. Physiol. 153, 557–562.PubMedCrossRefGoogle Scholar
  21. 21.
    Mandriota, S. J., Seghezzi, G., Vassalli, J. D., Ferrara, N., Wasi, S., Mazzieri, R., Mignatti, P., and Pepper, M. S. (1995) Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J. Biol. Chem. 270, 9709–9716.PubMedCrossRefGoogle Scholar
  22. 22.
    Pekala, P. Marlow, M., Heuvelman, D., and Connolly, D. (1990) Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J. Biol. Chem. 265 18,051–18,054.Google Scholar
  23. 23.
    Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. (1995) Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol. 146, 1029–1039.PubMedGoogle Scholar
  24. 24.
    Dvorak, H. F. (1986) Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Eng. J. Med. 315, 1650–1659.CrossRefGoogle Scholar
  25. 25.
    Dvorak, H. F., Harvey, V. S., Estrella, P., Brown, L. F., McDonagh, J., and Dvorak, A. M. (1987) Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab. Invest. 57, 673–686.Google Scholar
  26. 26.
    Roberts, W. G. and Palade, G. E. (1995) Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 108, 2369–2379.PubMedGoogle Scholar
  27. 27.
    Roberts, W. G. and Palade, G. E. (1997) Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 57, 765–772.PubMedGoogle Scholar
  28. 28.
    Melder, R. J., Koenig, G. C., Witwer, B. P., Safabakhsh, N., Munn, L. L., and Jain, R. K. (1996) During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium. Nature Med. 2, 992–997.Google Scholar
  29. 29.
    Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., et al. (1990) Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172, 1535–1545.PubMedCrossRefGoogle Scholar
  30. 30.
    Broxmeyer, H. E., Cooper, S., Li, Z. H., Lu, L., Song, H. Y., Kwon, B. S., Warren, R. E., and Donner, D. B. (1995) Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor. Int. J. Hematol. 62, 203–215.PubMedCrossRefGoogle Scholar
  31. 31.
    Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., and Carbone, D. P. (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med. 2, 1096–1103.PubMedCrossRefGoogle Scholar
  32. 32.
    Ku, D. D., Zaleski, J. K., Liu, S., and Brock, T. A. (1993) Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am. J. Physiol. 265, H586 — H592.PubMedGoogle Scholar
  33. 33.
    Yang, R., Thomas, G. R., Bunting, S., Ko, A., Ferrara, N., Keyt, B., Ross, J., and Jin, H. (1996) Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. J. Cardiovasc. Pharmacol. 27, 838–844.PubMedCrossRefGoogle Scholar
  34. 34.
    Cuevas, P., Carceller, F., Ortega, S., Zazo, M., Nieto, I., and Gimenez-Gallego, G. (1991) Hypotensive activity of fibroblast growth factor. Science 254, 1208–1210.PubMedCrossRefGoogle Scholar
  35. 35.
    Cuevas, P., Garcia-Calvo, M., Carceller, F., Reimers, D., Zazo, M., Cuevas, B., et al. (1996) Correction of hypertension by normalization of endothelial levels of fibroblast growth factor and nitric oxide synthase in spontaneously hypertensive rats. Proc. Natl. Acad. Sci. USA 93, 11,996–12, 001.Google Scholar
  36. 36.
    Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., and Leung, D. W. (1991) Vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5, 1806–1814.PubMedCrossRefGoogle Scholar
  37. 37.
    Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J. C., and Abraham, J. A. (1991) Human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 11,947–11, 954.Google Scholar
  38. 38.
    Vincenti, V., Cassano, C., Rocchi, M., and Persico, G. (1966) Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93, 1493–1495.CrossRefGoogle Scholar
  39. 39.
    Shima, D. T., Kuroki, M., Deutsch, U., Ng, Y. S., Adamis, A. P., and D’Amore, P. A. (1996) The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences. J. Biol. Chem. 271, 3877–3883.PubMedCrossRefGoogle Scholar
  40. 40.
    Levy, A. P., Levy, N. S., and Goldberg, M. A. (1996) Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem. 271, 2746–2753.PubMedCrossRefGoogle Scholar
  41. 41.
    Conn, G., Bayne, M. L., Soderman, D. D., Kwok, P. W., Sullivan, K. A., Palisi, T. M., Hope, D. A., and Thomas, K. A. (1990) Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc. Natl. Acad. Sci. USA 87, 2628–2632.PubMedCrossRefGoogle Scholar
  42. 42.
    Ferrara, N. and Henzel, W. J. (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161, 851–858.PubMedCrossRefGoogle Scholar
  43. 43.
    Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., and Ferrara, N. (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J. Biol. Chem. 267, 26,031–26, 037.Google Scholar
  44. 44.
    Park, J. E., Keller, H.-A., and Ferrara, N. (1993) The vascular endothelial growth factor isoforms (VEGF): differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4, 1317–1326.PubMedGoogle Scholar
  45. 45.
    Keyt, B. A., Berleau, L. T., Nguyen, H. V., Chen, H., Heinsohn, H., Vandlen, R., and Ferrara, N. (1996) Carboxyl-terminal domain (111–165) of vascular endothelial growth factor is critical for its mitogenic potency. J. Biol. Chem. 271, 7788–7795.PubMedCrossRefGoogle Scholar
  46. 46.
    Poltorak, Z., Cohen, T., Sivan, R., Kandelis, Y., Spira, G., Vlodaysky, I., Keshet, E., and Neufeld, G. (1997) VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J. Biol. Chem. 272, 7151–7158.PubMedCrossRefGoogle Scholar
  47. 47.
    Muller, Y. A., Li, B., Christinger, H. W., Wells, J. A., Cunningham, B. C., and de Vos, A. M. (1997) Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. Proc. Natl. Acad. Sci. USA 94, 7192–7197.PubMedCrossRefGoogle Scholar
  48. 48.
    Minchenko, A., Bauer, T., Salceda, S., and Caro, J. (1994) Hypoxic stimulation of vascular endothelial growth factor expression in vivo and in vitro. Lab. Invest. 71, 374–379.PubMedGoogle Scholar
  49. 49.
    Shima, D. T., Adamis, A. P., Ferrara, N., Yeo, K. T., Yeo, T. K., Allende, R., Folkman, J., and D’Amore, P. A. (1995) Hypoxic induction of endothelial cell growth factors in retinal cells: identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Mol. Med. 1, 182–193.PubMedGoogle Scholar
  50. 50.
    Banai, S., Shweiki. D., Pinson, A., Chandra, M., Lazarovich, G., and Keshet, E. (1994) Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: implications for coronary angiogenesis. Cardiovasc. Res. 28, 1176–1179.Google Scholar
  51. 51.
    Hashimoto, E., Ogita, T., Nakaoka, T., Matsuoka, R., Takao, A., and Kira, Y. (1994) Rapid induction of vascular endothelial growth factor expression by transient ischemia in rat heart. Am. J. Physiol. 267, H 1948–1954.Google Scholar
  52. 52.
    Stone, J., Itin, A., Alon, T., Pe’er, J., Gnessin, H., Chan Ling, T., and Keshet, E. (1995) Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neurosci. 15, 4738–4747.PubMedGoogle Scholar
  53. 53.
    Goldberg, M. A. and Schneider, T. J. (1994) Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269, 4355–4361.PubMedGoogle Scholar
  54. 54.
    Levy, A. P., Levy, N. S., Wegner, S., and Goldberg, M. A. (1995) Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270, 13,333–13, 340.Google Scholar
  55. 55.
    Liu, Y., Cox, S. R., Morita, T., and Kourembanas, S. (1995) Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5’ enhancer. Circ. Res. 77, 638–643.PubMedCrossRefGoogle Scholar
  56. 56.
    Madan, A. and Curtin, P. T. (1993) A 24-base-pair sequence 3’ to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. Proc. Natl. Acad. Sci. USA 90, 3928–3932.PubMedCrossRefGoogle Scholar
  57. 57.
    Wang, G. L. and Semenza, G. L. (1995) Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 270, 1230–1237.PubMedCrossRefGoogle Scholar
  58. 58.
    Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604–4613.PubMedGoogle Scholar
  59. 59.
    Ikeda, E., Achen, M. G., Breier, G., and Risau, W. (1995) Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol. Chem. 270, 19,761–19, 766.Google Scholar
  60. 60.
    Frank, S., Hubner, G., Breier, G., Longaker, M. T., Greenhalg, D. G., and Werner, S. (1995) Regulation of VEGF expression in cultured keratinocytes. Implications for normal and impaited wound healing. J. Biol. Chem. 270, 12,607–12, 613.Google Scholar
  61. 61.
    Goldman, C., Kim, J., Wonf,W.-L., King, V., Brock, T., and Gillespie, Y. (1993) Epidermal growth factor stimulates vascular endothelial growth factor production by malignant glioma cells. A model of glioblastoma multiforme pathophysiology. Mol. Biol. Cell 4, 121–133.Google Scholar
  62. 62.
    Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., and Alitalo, K. (1994) Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J. Biol. Chem. 269, 6271–6274.PubMedGoogle Scholar
  63. 63.
    Li, J., Perrella, M. A., Tsai, J. C., Yet, S. F., Hsieh, C. M., Yoshizumi, M., et al. (1995) Induction of vascular endothelial growyh factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. J. Biol. Chem. 270, 308–312.PubMedCrossRefGoogle Scholar
  64. 64.
    Ben-Av, P., Crofford, L. J., Wilder, R. L., and Hla, T. (1995) Induction of vascular endothelial growth factor expression in synovial fibroblasts. FEBS Lett. 372, 83–87.PubMedCrossRefGoogle Scholar
  65. 65.
    Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G., and Levi, B. Z. (1996) Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem. 271, 736–741.Google Scholar
  66. 66.
    Warren, R. S., Yuan, H., Matli, M. R., Ferrara, N., and Donner, D. B. (1996) Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. J. Biol. Chem. 271, 29,483–29, 488.Google Scholar
  67. 67.
    Claffey, K. P., Wilkison, W. O., and Spiegelman, B. M. (1992) Vascular endothelial growth factor regulation by cell differentiation and activated second messenger pathways. J. Biol. Chem. 267, 16,317–16, 322.Google Scholar
  68. 68.
    Kieser, A., Weich, H., Brandner, G., Marme, D., and Kolch, W. (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9, 963–969.PubMedGoogle Scholar
  69. 69.
    Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. (1995) Mutant ras oncogenes upregulate VEGFNPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 55, 4575–4580.PubMedGoogle Scholar
  70. 70.
    Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., and Marme, D. (1995) Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem. 270, 25,915–25, 919.Google Scholar
  71. 71.
    Mazure, N. M., Chen, E. Y., Yeh, P., Laderoute, K. R., and Giaccia, A. J. (1996) Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res. 56, 3436–3440.PubMedGoogle Scholar
  72. 72.
    Siemeister, G., Weindel, K., Mohrs, K., Barleon, B., Martiny Baron, G., and Marme, D. (1996) Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. Cancer Res. 56, 2299–2301.Google Scholar
  73. 73.
    Iliopoulos, O., Levy, A. P., Jiang, C., Kadin, W. G., Jr., and Goldberg, M. A. (1996) Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA 93,10, 595–10, 599.Google Scholar
  74. 74.
    Gnarra, J. R., Zhou, S., Merrill, M. J., Wagner, J. R., Krumm, A., Papavassiliou, E., et al. (1996) Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA 93, 10,589–10, 594.Google Scholar
  75. 75.
    Vaisman, N., Gospodarowicz, D., and Neufeld, G. (1990) Characterization of the receptors for vascular endothelial growth factor. J. Biol. Chem. 265, 19,461–19, 466.Google Scholar
  76. 76.
    Plouet, J. and Moukadiri, H. J. (1990) Characterization of the receptors for vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. J. Biol. Chem. 265, 22,071–22, 075.Google Scholar
  77. 77.
    Shen, H., Clauss, M., Ryan, J., Schmidt, A. M., Tijburg, P., Borden, L., et al. (1993) Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81, 2767–2773.PubMedGoogle Scholar
  78. 78.
    Jakeman, L. B., Winer, J., Bennett, G. L., Altar, C. A., and Ferrara, N. (1992) Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. J. Clin. Invest. 89, 244–253.PubMedCrossRefGoogle Scholar
  79. 79.
    Jakeman, L. B., Armanini, M., Philips, H. S., and Ferrara, N. (1993) Developmental expression of binding sites and mRNA for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133, 848–859.PubMedCrossRefGoogle Scholar
  80. 80.
    de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., and Williams, L. T. (1992) fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989–991.Google Scholar
  81. 81.
    Terman, B. I., Dougher Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Bohlen, P. (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187, 1579–1586.PubMedCrossRefGoogle Scholar
  82. 82.
    Matthews, W., Jordan, C. T., Gavin, M., Jenkins, N. A., Copeland, N. G., and Lemischka, I. R. (1991) Receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. USA 88, 9026–9030.PubMedCrossRefGoogle Scholar
  83. 83.
    Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., and Sato, M. (1990) Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely related to the fms family. Oncogene 8, 519–527.Google Scholar
  84. 84.
    Terman, B. I., Carrion, M. E., Kovacs, E., Rasmussen, B. A., Eddy, R. L., and Shows, T. B. (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6, 1677–1683.PubMedGoogle Scholar
  85. 85.
    Kendall, R. L., Wang, G., and Thomas, K. A. (1996) Identification of a natural soluble form of the vascular endothelial growth factor receptor. FLT-1, and its heterodimerization with KDR. Biochem. Biophys. Res. Commun. 226, 324–328.PubMedCrossRefGoogle Scholar
  86. 86.
    Pajusola, K., Aprelikova, O., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R., and Alitalo, K. (1992) FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res. 52, 5738–5743.PubMedGoogle Scholar
  87. 87.
    Galland, F., Karamysheva, A., Mattei, M. G., Rosnet, O., Marchetto, S., and Birnbaum, D. (1992) Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene. Genomics 13, 475–478.PubMedCrossRefGoogle Scholar
  88. 88.
    Finnerty, H., Kelleher, K., Morris, G. E., Bean, K., Merberg, D. M., Kriz, R., et al. (1993) Molecular cloning of murine FLT and FLT4. Oncogene 8, 2293–2298.PubMedGoogle Scholar
  89. 89.
    Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., et al. (1996) Novel vascular endothelial growth factor. VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 1751.PubMedGoogle Scholar
  90. 90.
    Lee, J., Gray, A., Yuan, J., Luoh, S. M., Avraham, H., and Wood, W. I. (1996) Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl. Acad. Sci. USA 93, 1988–1992.PubMedCrossRefGoogle Scholar
  91. 91.
    Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., et al. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276, 1423–1425.PubMedCrossRefGoogle Scholar
  92. 92.
    Davis-Smyth, T. Chen, H., Park, J., Presta, L. G., and Ferrara, N. (1996) Second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO J. 15 4919–4927.Google Scholar
  93. 93.
    Chamow, S. M. and Ashkenazi, A. (1996) Immunoadhesins: principles and applications. Trends Biotechnol. 14, 52–60.PubMedCrossRefGoogle Scholar
  94. 94.
    Guo, D., Jia, Q., Song, H. Y., Warren, R. S., and Donner, D. B. (1995) Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem. 270, 6729–6733.PubMedCrossRefGoogle Scholar
  95. 95.
    Morbidelli, L., Chang, C. H., Douglas, J. G., Granger, H. J., Ledda, F., and Ziche, M. (1996) Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am. J. Physiol. 270, H411 - H415.PubMedGoogle Scholar
  96. 96.
    Waltenberger, J., Claesson Welsh, L., Siegbahn, A., Shibuya, M., and Heldin, C. H. (1994) Different signal transduction properties of KDR and Fltl, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269, 26,988–26, 995.Google Scholar
  97. 97.
    Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S., and Shibuya, M. (1995) A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10, 135–147.PubMedGoogle Scholar
  98. 98.
    Park, J. E., Chen, H. H., Winer, J., Houck, K. A., and Ferrara, N. (1994) Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J. Biol. Chem. 269, 25,646–25, 654.Google Scholar
  99. 99.
    Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H., and Ferrara, N. (1996) Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis. J. Biol. Chem. 271, 5638–5646.PubMedCrossRefGoogle Scholar
  100. 100.
    Cunningham, S. A., Waxham, M. N., Arrate, P. M., and Brock, T. A. (1995) Interaction of the Flt-1 tyrosine kinase receptor with the p85 subunit of phosphatidylinositol 3-kinase. Mapping of a novel site involved in binding. J. Biol. Chem. 270, 20,254–20, 257.Google Scholar
  101. 101.
    Barleon, B., Sozzani, S., Zhou, D., Weich, H. A., Mantovani, A., and Marme, D. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336–3343.Google Scholar
  102. 102.
    Morishita, K., Johnson, D. E., and Williams, L. T. (1995) Novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression. J. Biol. Chem. 270, 27,948–27, 953.Google Scholar
  103. 103.
    Patterson, C., Perrella, M. A., Hsieh, C. M., Yoshizumi, M., Lee, M. E., and Haber, E. (1995) Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J. Biol. Chem. 270, 23,111–23, 118.Google Scholar
  104. 104.
    Tuder, R. M., Flook, B. E., and Voelkel, N. F. (1995) Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J. Clin. Invest. 95, 1798–1807.PubMedCrossRefGoogle Scholar
  105. 105.
    Li, J., Brown, L. F., Hibberd, M. G., Grossman, J. D., Morgan, J. P., and Simons, M. (1996) VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am. J. Physiol. 270, H1803 - H1811.PubMedGoogle Scholar
  106. 106.
    Takagi, H., King, G. L., Ferrara, N., and Aiello, L. P. (1996) Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest. Ophthalmol. Vis. Sci. 37, 1311–1321.PubMedGoogle Scholar
  107. 107.
    Brogi, E., Schatteman, G., Wu, T., Kim, E. A., Varticovski, L., Keyt, B., and Isner, J. M. (1996) Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. J. Clin. Invest. 97, 469–476.Google Scholar
  108. 108.
    Gerber, H. P., Condorelli, F., Park, J., and Ferrara, N. (1997) Differential transcriptional regulation of the two VEGF receptor genes. Flt-1, but not Flk-1 /KDR, is up-regulated by hypoxia. J. Biol. Chem. 272, 23,659–23, 667.Google Scholar
  109. 109.
    Patterson, C., Perrella, M. A., Endege, W. O., Yoshizumi, M., Lee, M. E., and Haber, E. (1996) Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor-alpha in cultured human vascular endothelial cells. J. Clin. Invest. 98, 490–496.PubMedCrossRefGoogle Scholar
  110. 110.
    Mandriota, S. J., Menoud, P. A., and Pepper, M. S. (1996) Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells. J. Biol. Chem. 271, 11,500–11, 505.Google Scholar
  111. 111.
    Breier, G., Albrecht, U., Sterrer, S., and Risau, W. (1992) Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114, 521–532.PubMedGoogle Scholar
  112. 112.
    Shifren, J. L., Doldi, N., Ferrara, N., Mesiano, S., and Jaffe, R. B. (1994) In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. J. Clin. Endocrino!. Metab. 79, 316–322.CrossRefGoogle Scholar
  113. 113.
    Quinn, T. P., Peters, K. G., De Vries, C., Ferrara, N., and Williams, L. T. (1993) Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl. Acad. Sci. USA 90, 7533–7537.PubMedCrossRefGoogle Scholar
  114. 114.
    Millauer, B., Wizigmann Voos, S., Schnurch, H., Martinez, R., Moller, N. P., Risau, W., and Ullrich, A. (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835–846.PubMedCrossRefGoogle Scholar
  115. 115.
    Yamaguchi, T. P., Dumont, D. J., Conlon, R. A., Breitman, M. L., and Rossant, J. (1993) flk-1, an fltrelated receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118, 489–498.Google Scholar
  116. 116.
    Peters, K. G., De Vries, C., and Williams, L. T. (1993) Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl. Acad. Sci. USA 90, 8915–8919.PubMedCrossRefGoogle Scholar
  117. 117.
    Ferrara, N., Houck, K., Jakeman, L., and Leung, D. W. (1992) Molecular and biological properties of the vascular endothelial growth facmily of proteins. Endocr. Rev. 13, 18–32.PubMedGoogle Scholar
  118. 118.
    Monacci, W. T., Merrill, M. J., and Oldfield, E. H. (1993) Expression of vascular permeability factor/ vascular endothelial growth factor in normal rat tissues. Am. J. Physiol. 264, C995 - C1002.PubMedGoogle Scholar
  119. 119.
    Alon, T., Hemo, I., Itin, A., Pe’er, J., Stone, J., and Keshet, E. (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Med. 1, 1024–1028.PubMedCrossRefGoogle Scholar
  120. 120.
    Fong, G. H., Rossant, J., Gertsenstein, M., and Breitman, M. L. (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66–70.PubMedCrossRefGoogle Scholar
  121. 121.
    Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A. C. (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62–66.PubMedCrossRefGoogle Scholar
  122. 122.
    Brandon, E. P., Idzerda, R. L., and McKnight, G. S. (1995) Targeting the mouse genome: a compendium of knockouts (part III). Curr. Biol. 5, 873–881.PubMedCrossRefGoogle Scholar
  123. 123.
    Carmeliet, P. and Collen, D. (1997) Genetic analysis of blood vessel formation: role of endothelial versus smooth muscle cells. Trends Cardiovasc. Med. 8, 271–281.CrossRefGoogle Scholar
  124. 124.
    Phillips, H. S., Hains, J., Leung, D. W., and Ferrara, N. (1990) Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 127, 965–967.PubMedCrossRefGoogle Scholar
  125. 125.
    Ravindranath, N., Little-Ihrig, L., Phillips, H. S., Ferrara, N., and Zeleznik, A. J. (1992) Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 131, 254–260.PubMedCrossRefGoogle Scholar
  126. 126.
    Shweiki, D., Itin, A., Neufeld, G., Gitay-Goren, H., and Keshet, E. (1993) Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally-mediated angiogenesis. J. Clin. Invest. 91, 2235–2243.PubMedCrossRefGoogle Scholar
  127. 127.
    Cullinan-Bove, K. and Koos, R. D. (1993) Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133, 829–837.PubMedCrossRefGoogle Scholar
  128. 128.
    Ferrara, N., Chen, H., Davis-Smyth, T., Gerber, H.-P., Nguyen, T.-N., Peers, D., et al. (1998) Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Med. 4, 336–340.PubMedCrossRefGoogle Scholar
  129. 129.
    Volm, M., Koomagi, R., Mattem, J., and Stammler, G. (1997) Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. Anticancer Res. 17, 99–103.PubMedGoogle Scholar
  130. 130.
    Volm, M., Koomagi, R., and Mattem, J. (1997) Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int. J. Cancer 74, 64–68.PubMedCrossRefGoogle Scholar
  131. 131.
    Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Guidi, A. J., Dvorak, H. F., et al. (1995) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum. Pathol. 26, 86–91.PubMedCrossRefGoogle Scholar
  132. 132.
    Yoshiji, H., Gomez, D. E., Shibuya, M., and Thorgeirsson, U. P. (1996) Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. CancerRes. 56, 2013–2016.Google Scholar
  133. 133.
    Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. (1993) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. 53, 4727–4735.PubMedGoogle Scholar
  134. 134.
    Suzuki, K., Hayashi, N., Miyamoto, Y., Yamamoto, M., Ohkawa, K., Ito, Y., et al. (1996) Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res. 56, 3004–3009.PubMedGoogle Scholar
  135. 135.
    Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H. F., and Senger, D. R. (1993) Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Pathol. 143, 1255–1262.PubMedGoogle Scholar
  136. 136.
    Olson, T. A., Mohanraj, D., Carson, L. F., and Ramakrishnan, S. (1994) Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res. 54, 276–280.PubMedGoogle Scholar
  137. 137.
    Guidi, A. J., Abu Jawdeh, G., Tognazzi, K., Dvorak, H. F., and Brown, L. F. (1996) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. Cancer 78, 454–460.PubMedCrossRefGoogle Scholar
  138. 138.
    Guidi, A. J., Abu-Jawdeh, G., Berse, B., Jackman, R. W., Tognazzi, K., Dvorak, H. F., and Brown, L. F. (1995) Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J.Natl. Cancer Inst. 87, 1237–1245.PubMedCrossRefGoogle Scholar
  139. 139.
    Hashimoto, M., Ohsawa, M., Ohnishi, A., Naka, N., Hirota, S., Kitamura, Y., and Aozasa, K. (1995) Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Lab. Invest. 73, 859–863.PubMedGoogle Scholar
  140. 140.
    Viglietto, G., Romano, A., Maglione, D., Rambaldi, M., Paoletti, I., Lago, C. T., et al. (1996) Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor. Oncogene 13, 577–587.PubMedGoogle Scholar
  141. 141.
    Shweiki, D., Itin, A., Soffer, D., and Keshet, E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843–845.PubMedCrossRefGoogle Scholar
  142. 142.
    Plate, K. H., Breier, G., Weich, H. A., and Risau, W. (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359, 845–848.PubMedCrossRefGoogle Scholar
  143. 143.
    Phillips, H. S., Armanini, M., Stavrou, D., Ferrara, N., and Westphal, M. (1993) Intense focal expression of vascular endothelial growth factor mRNA in human intracranial neoplasms: association with regions of necrosis. Int. J. Oncol. 2, 913–919.PubMedGoogle Scholar
  144. 144.
    Berkman, R. A., Merrill, M. J., Reinhold, W. C., Monacci, W. T., Saxena, A., Clark, W. C., et al. (1993) Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J. Clin. Invest. 91, 153–159.PubMedCrossRefGoogle Scholar
  145. 145.
    Wizigmann Voos, S., Breier, G., Risau, W., and Plate, K. H. (1995) Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res. 55, 1358–1364.PubMedGoogle Scholar
  146. 146.
    Plate, K. H., Breier, G., Millauer, B., Ullrich, A., and Risau, W. (1993) Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model oftumor angiogenesis. Cancer Res. 53, 5822–5827.PubMedGoogle Scholar
  147. 147.
    Ferrara, N., Winer, J., Burton, T., Rowland, A., Siegel, M., Phillips, H. S., et al. (1993) Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to Chinese hamster ovary cells. J. Clin. Invest. 91, 160–170.PubMedCrossRefGoogle Scholar
  148. 148.
    Qu, H., Nagy, J. A., Senger, D. R., Dvorak, H. F., and Dvorak, A. M. (1995) Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPFNEGF) to the abluminal plasma membrane and vesiculovacuolar organelles oftumor microvascular endothelium. J. Histochem. Cytochem. 43, 381–389.CrossRefGoogle Scholar
  149. 149.
    Albini, A., Benelli, R., Presta, M., Rusnati, M., Ziche, M., Rubartelli, A., et al. (1996) HIV-tat protein is a heparin-binding angiogenic growth factor. Oncogene 12, 289–297.PubMedGoogle Scholar
  150. 150.
    Albini, A., Soldi, R., Giunciuglio, D., Giraudo, E., Benelli, R., Primo, L., et al. (1996) Angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nature Med. 2, 1371–1375.PubMedCrossRefGoogle Scholar
  151. 151.
    Kondo, S., Asano, M., Matsuo, K., Ohmori, I., and Suzuki, H. (1994) Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta. 1221, 211–214.PubMedCrossRefGoogle Scholar
  152. 152.
    Toi, M., Kondo, S., Suzuki, H., Yamamoto, Y., Inada, K., Imazawa, T., Taniguchi, T., and Tominaga, T. (1996) Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer 77, 1101–1106.PubMedCrossRefGoogle Scholar
  153. 153.
    Gasparini, G., Toi, M., Gion, M., Verderio, P., Dittadi, R., Hanatani, M., et al. (1997) Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. Natl. Cancer Inst. 89, 139–147.PubMedCrossRefGoogle Scholar
  154. 154.
    Maeda, K., Chung, Y. S., Ogawa, Y., Takatsuka, S., Kang, S. M., Ogawa, M., Sawada, T., and Sowa, M. (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77, 858–863.PubMedCrossRefGoogle Scholar
  155. 155.
    Kim, K. J., Li, B., Houck, K., Winer, J., and Ferrara, N. (1992) Vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 7, 53–64.PubMedCrossRefGoogle Scholar
  156. 156.
    Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362, 841–844.PubMedCrossRefGoogle Scholar
  157. 157.
    Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., and Ferrara, N. (1995) Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J. Clin. Invest. 95, 1789–1797.PubMedCrossRefGoogle Scholar
  158. 158.
    Melnyk, O., Shuman, M. A., and Kim, K. J. (1996) Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. Cancer Res. 56, 921–924.PubMedGoogle Scholar
  159. 159.
    Asano, M., Yukita, A., Matsumoto, T., Kondo, S., and Suzuki, H. (1995) Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121. Cancer Res. 55, 5296–5301.PubMedGoogle Scholar
  160. 160.
    Borgstrom, P., Hillan, K. J., Sriramarao, P., and Ferrara, N. (1996) Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. Cancer Res. 56, 4032–4039.PubMedGoogle Scholar
  161. 161.
    Kirshembaum, A., Wang. J.-P., Ren, M., Schiff, J. D., Aaronson, S. A., Droller, M. J., et al. (1997) Inhibition of vascular endothelial growth factor suppresses the in vivo growth of human prostate tumors. Urol Oncol. 3, 3–10.Google Scholar
  162. 162.
    Borgstrom, P., Hillan, K. J., Sriraramao, P., and Ferrara, N. Combination treatment with anti-vascular endothelial growth factor antibody and doxorubicin suppresses growth of breast carcinoma cells, submitted.Google Scholar
  163. 163.
    Yuan, F., Chen, Y., Dellian, M., Safabakhsh, N., Ferrara, N., and Jain, R. K. (1996) Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc. Natl. Acad. Sci. USA 93,14, 765–14, 770.Google Scholar
  164. 164.
    Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367, 576–579.PubMedCrossRefGoogle Scholar
  165. 165.
    Millauer, B., Longhi, M. P., Plate, K. H., Shawver, L. K., Risau, W., Ullrich, A., and Strawn, L. M. (1996) Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo. Cancer Res. 56, 1615–1620.PubMedGoogle Scholar
  166. 166.
    Olk, R. J. and Lee, C. M. (1993) Diabetic Retinopathy: Practical Management. Lippincott, Philadelphia.Google Scholar
  167. 167.
    Patz, A. (1980) Studies on retinal neovascularization. Invest. Ophthalmol. Vis. Sci. 19, 1133–1138.PubMedGoogle Scholar
  168. 168.
    Michaelson, I. C. (1948) The mode of development of the vascular system of the retina with some observations on its significance for certain retinal disorders. Trans. Ophthalmol. Soc. U. K. 68, 137–180.Google Scholar
  169. 169.
    Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., et al. (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N. Eng. J. Med. 331, 1480–1487.CrossRefGoogle Scholar
  170. 170.
    Adamis, A. P., Miller, J. W., Bernal, M. T., D’Amico, D. J., Folkman, J., Yeo, T. K., and Yeo, K. T. (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am. J. Ophthalmol. 118, 445–450.PubMedGoogle Scholar
  171. 171.
    Malecaze, F., Clemens, S., Simorer-Pinotel, V., Mathis, A., Chollet, P., Favard, P., Bayard, F., and Plouet, J. (1994) Detection of vascular endothelial growth factor mRNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch. Ophthalmol. 112, 1476–1482.PubMedCrossRefGoogle Scholar
  172. 172.
    Miller, J. W., Adamis, A. P., Shima, D. T., D’Amore, P. A., Moulton, R. S., O’Reilly, M. S., et al. (1994) Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am. J. Pathol. 145, 574–584.PubMedGoogle Scholar
  173. 173.
    Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., and Smith, L. E. (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. USA 92, 905–909.PubMedCrossRefGoogle Scholar
  174. 174.
    Adamis, A. P., Shima, D. T., Tolentino, M. J., Gragoudas, E. S., Ferrara, N., Folkman, J., D’Amore, P. A., and Miller, J. W. (1996) Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch. Ophthalmol. 114, 66–71.PubMedCrossRefGoogle Scholar
  175. 175.
    Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., et al. (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. USA 92, 10,457–10, 461.Google Scholar
  176. 176.
    Lopez, P. F., Sippy, B. D., Lambert, H. M., Thach, A. B., and Hinton, D. R. (1996) Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci. 37, 855–868.PubMedGoogle Scholar
  177. 177.
    Kvanta, A., Algvere, P. V., Berglin, L., and Seregard, S. (1996) Subfoveal fibrovascular membranes in age-related macular degeneration express vascular endothelial growth factor. Invest. Ophthalmol. Vis. Sci. 37, 1929–1934.PubMedGoogle Scholar
  178. 178.
    Koch, A. E., Harlow, L., Haines, G. K., Amento, E. P., Unemori, E. N., Wong, W.-L., Pope, R. M., and Ferrara, N. (1994) Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J. Immunol. 152, 4149–4156.PubMedGoogle Scholar
  179. 179.
    Fava, R. A., Olsen, N. J., Spencer-Green, G., Yeo, K. T., Yeo, T. K., Berse, B., et al. (1994) Vascular permeability factor/endothelial growth factor (VPFNEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J. Exp. Med. 180, 341–346.PubMedCrossRefGoogle Scholar
  180. 180.
    Fassbender, H. J. and Simling-Annenfeld, M. (1983) The potential aggressiveness of synovial tissue in rheumatoid arthritis. J Pathol. 10, 845–851.Google Scholar
  181. 181.
    Detmar, M., Brown, L. F., Claffey, K. P., Yeo, K. T., Kocher, O., Jackman, R. W., Berse, B., and Dvorak, H. F. (1994) Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. J Exp. Med. 180, 1141–1146.PubMedCrossRefGoogle Scholar
  182. 182.
    Brown, L. F., Harrist, T. J., Yeo, K. T., Stahle-Backdahl, M., Jackman, R. W., Berse, B., et al. (1995) Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J. Invest. Dermatol. 104, 744–749.PubMedCrossRefGoogle Scholar
  183. 183.
    McLaren, J., Prentice, A., Charnock-Jones, D. S., and Smith, S. K. (1996) Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum. Reprod. 11, 220–223.PubMedCrossRefGoogle Scholar
  184. 184.
    Shifren, J. L., Tseng, J. F., Zaloudek, C. J., Ryan, I. P., Meng, Y. G., Ferrara, N., Jaffe, R. B., and Taylor, R. N. (1996) Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin. Endocrinol. Metab. 81, 3112–3118.Google Scholar
  185. 185.
    Kamat, B. R., Brown, L. F., Manseau, E. J., Senger, D. R., and Dvorak, H. F. (1995) Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am. J. Pathol. 146, 157–165.Google Scholar
  186. 186.
    Sato, K., Yamazaki, K., Shizume, K., Kanaji, Y., Obara, T., Ohsumi, K., et al. (1995) Stimulation by thyroid-stimulating hormone and Grave’s immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. J Clin. Invest. 96, 1295–1302.PubMedCrossRefGoogle Scholar
  187. 187.
    Kuhn, R., Schwenk, F., Aguet, M., and Rajewsky, K. (1995) Inducible gene targeting in mice. Science 269, 1427–1429.PubMedCrossRefGoogle Scholar
  188. 188.
    Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., and Cheresh, D. A. (1995) Definition of two angiogenic pathways by distinct alpha v integrins. Science 270, 1500–1502.PubMedCrossRefGoogle Scholar
  189. 189.
    Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., et al. (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161–1169.PubMedCrossRefGoogle Scholar
  190. 190.
    Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., and Yancopoulos, G. D. (1996) Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171–1180.PubMedCrossRefGoogle Scholar
  191. 191.
    Maisonpierre, P.C., Suri, C., Jones, P. F., Bartunkova, S., Wiegend, S. J., Radziejewski, C., et al. (1997) Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science 277, 55–60.PubMedCrossRefGoogle Scholar
  192. 192.
    Presta, L. G., Chen, H., O’Connor, S. J., Chisholm, V., Meng, Y. G., Krummen, L., Winkler, M., and Ferrara, N. (1997) Humanization of an anti-VEGF monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res. 57, 4593–4599.Google Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Napoleone Ferrara

There are no affiliations available

Personalised recommendations